Option Care Health (NASDAQ:OPCH - Get Free Report) will likely be releasing its earnings data before the market opens on Wednesday, February 26th. Analysts expect Option Care Health to post earnings of $0.33 per share and revenue of $1.29 billion for the quarter. Persons that are interested in registering for the company's earnings conference call can do so using this link.
Option Care Health Trading Down 1.2 %
Option Care Health stock traded down $0.39 during midday trading on Friday, reaching $32.00. The stock had a trading volume of 1,771,776 shares, compared to its average volume of 1,711,993. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The firm has a market cap of $5.45 billion, a price-to-earnings ratio of 26.89, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a fifty day moving average of $27.54 and a 200 day moving average of $27.97.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on OPCH. JMP Securities reissued a "market outperform" rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a "neutral" rating and a $26.00 target price on the stock. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $32.25.
View Our Latest Stock Report on Option Care Health
About Option Care Health
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
